Hemp Planting Predictability Act
Summary
The Hemp Planting Predictability Act (S3686) proposes to delay stricter federal controls on hemp products until November 12, 2028. This bill, currently in early stages, aims to extend the current regulatory environment, providing stability for companies in the hemp-derived product and agricultural supply sectors. The bill does not include explicit funding.
Key Takeaways
- 1.The Hemp Planting Predictability Act (S3686) proposes to delay stricter federal hemp controls until November 12, 2028.
- 2.This bill aims to provide regulatory stability for hemp-derived product companies and agricultural suppliers.
- 3.The bill is in the early stages of the legislative process, having been referred to the Senate Committee on Agriculture, Nutrition, and Forestry.
Market Implications
The potential delay in stricter hemp regulations, if S3686 passes, would provide a period of continued stability for companies operating in the hemp and cannabis-related agricultural sectors. This regulatory predictability could reduce uncertainty for businesses like Tilray Brands, Inc. ($TLRY) and SNDL Inc. ($SNDL), which are directly involved in the cannabis and hemp markets, and The Scotts Miracle-Gro Company ($SMG), a supplier to growers. However, the bill is in early legislative stages, and its impact on current market prices for these tickers is not evident in the recent 7-day and 30-day changes, which show mixed performance.
Full Analysis
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2026, to delay the implementation of amendments made by such Act to the hemp production provisions of the Agricultural Marketing Act of 1946.
American Hemp Protection Act of 2025
ACE Agriculture Act
Hemp Enforcement, Modernization, and Protection Act
Respect NATO Allies Act
Strong Start Act
Working Families Flexibility Act of 2025
To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes.